Search Results - "Weigand, Luise U."
-
1
Formin-like 1 (FMNL1) Is Regulated by N-terminal Myristoylation and Induces Polarized Membrane Blebbing
Published in The Journal of biological chemistry (27-11-2009)“…The formin protein formin-like 1 (FMNL1) is highly restrictedly expressed in hematopoietic lineage-derived cells and has been previously identified as a…”
Get full text
Journal Article -
2
349 A novel ‘off the shelf’ TCR-NK cell therapy platform for the treatment of solid tumours: development of optimised MAGE-A4 targeting TCR-NK cells for advancement into the clinic
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundT cell receptor (TCR)-T based therapies, such as MAGE-A4 TCR-T cells, have shown compelling data demonstrating effective infiltration into and…”
Get full text
Journal Article -
3
A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire
Published in The Journal of immunology (1950) (01-02-2010)“…T cells can recognize tumor cells specifically by their TCR and the transfer of TCR-engineered T cells is a promising novel tool in anticancer therapies. We…”
Get full text
Journal Article -
4
Isolation of human MHC class II‐restricted T cell receptors from the autologous T‐cell repertoire with potent anti‐leukaemic reactivity
Published in Immunology (01-11-2012)“…Summary Adoptive transfer of T cells genetically modified with tumour‐specific T‐cell receptors (TCR) is a promising novel approach in the treatment of cancer…”
Get full text
Journal Article -
5
Abstract 1329: Development of the first optimised “off the shelf” MAGE-A4 targeting TCR-NK cells for advancement into the clinic for the treatment of solid tumors
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract T cell receptor (TCR)-T based therapies, such as MAGE-A4 TCR-T cells, have shown compelling data demonstrating effective infiltration into and…”
Get full text
Journal Article -
6
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific
Published in PloS one (15-10-2018)“…Robust preclinical testing is essential to predict clinical safety and efficacy and provide data to determine safe dose for first-in-man studies. There are a…”
Get full text
Journal Article -
7
Abstract 2805: Cancer-specific T cell receptor isolation for cancer immunotherapy
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Malignant cells may be recognized by T cells binding cell surface Class I HLA-peptide complexes presenting disease-associated epitopes. Many cancer…”
Get full text
Journal Article -
8
Transfer of Human T-Cell Receptors (TCR) Containing Murine Chimeric Constant Beta-Gamma-Chain Sequences Reduces the Risk of Mixed Heterodimers and Shows Enhanced in Vitro-Accumulation of TCR-Tranduced Effector Cells
Published in Blood (20-11-2009)“…Abstract 3583 Poster Board III-520 Adoptive transfer of T-cell receptor (TCR)-transduced T cells may represent an attractive and promising novel approach to…”
Get full text
Journal Article -
9
A Single TCR{alpha}-Chain with Dominant Peptide Recognition in the Allorestricted HER2/neu-Specific T Cell Repertoire
Published in The Journal of immunology (1950) (01-02-2010)Get full text
Journal Article